Used primarily in scientific research as a selective agonist for nicotinic acetylcholine receptors, particularly the α4β2 subtype. It serves as a reference compound in neuropharmacological studies to investigate receptor function, neurotransmitter release, and neuronal signaling pathways. Due to its structural similarity to nicotine, it is employed in studies related to addiction, cognition, and neurodegenerative disorders such as Alzheimer's and Parkinson’s disease. It is also utilized in in vitro and in vivo assays to evaluate the potency and efficacy of novel nicotinic receptor ligands. Not intended for therapeutic use or human consumption.